相关实验视频

Updated: Sep 17, 2025

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

10.9K

单细胞衍生的巨细胞的转录组签名与雌激素受体通路抑制剂有关,在前列腺癌中进展

Marina Nasrin Sharifi1,2, Erika Heninger2,3, Matthew Leeson Bootsma4

  • 1Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.

The Prostate
|July 3, 2025
PubMed
概括

前列腺癌的进展涉及巨细胞的促炎基因特征. 基于此签名的新评分系统可能比目前的方法更早地检测治疗反应的变化.

关键词:
生物标志物生物标志物激素疗法激素疗法是一种激素疗法.巨细胞是什么?巨细胞是什么?单细胞 (Monocytes) 是一种单细胞.前列腺癌是前列腺癌.

更多相关视频

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

6.9K
MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR

Published on: May 16, 2012

24.7K

相关概念视频

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K